Skip to main content

3386 · COSMO BIO COMPANY, LIMITED · Financials

1,230 JPY +2 (+0.16%) At close · Nov 12
Market Cap
7.01B JPY
Shares
5.70M
Volume · Nov 12 1700 Avg daily vol (3M) 4093

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
10.77B +7.3%
FY2025 Revenue FY2021–FY2025
Net Income
337M +28.6%
FY2025 Net Income FY2021–FY2025
Gross Margin
34.39% +1.2pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
3.19% 0pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
595M +146.9%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 10.77B 10.04B 9.34B 9.55B 9.23B
JPY 7.06B 6.71B 6.09B 6.11B 5.57B
JPY 3.7B 3.33B 3.25B 3.44B 3.66B
JPY 343M 318M 519M 816M 1.05B
JPY 504M 369M 653M 790M 1.1B
JPY 170M 99M 191M 238M 330M
JPY 337M 262M 442M 517M 737M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: 1.18B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.